Bevacizumab may be Active in Myelofibrosis

By Nikolaidis Ilias   Makrilia Nektaria   Xyla Vassilia   Dilana Kalliopi   Stathopoulos Dimitris   Meletis Ioannis   Syrigos Kostas  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 111-112

Informa Healthcare

Access to resources Recommend Favorite

Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D.   Rolović Z.   Ćemerikić V.   Bošković D.   Ćolović M.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite

TP53 mutation is rare in primary myelofibrosis

By Greaves Wesley O.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1552-1552

Informa Healthcare

Access to resources Recommend Favorite

Hodgkin's lymphoma associated with myelofibrosis: A case report

By          

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1551-1554

Spandidos Publications

Access to resources Recommend Favorite

Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia

By Merup M.   Kutti J.   Birgergård G.   Mauritzson N.   Björkholm M.   Markevärn B.   Malm C.   Westin J.   Palmblad J.   Samuelsson J.  

Medical Oncology, Vol. 19, Iss. 2, 2002-06 ,pp. : 79-86

Humana Press, Inc

Access to resources Recommend Favorite